Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.37 |
| ▸ | PRKDC | P78527 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | TNKS | O95271 | 1/20 | 0.30 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25671829 | 0.91 | ALOX5 (0.43) | ALOX5PRKDCTNKSTNKS2 | |
| SCHEMBL12088895 | 0.90 | ALOX5 (0.39) | ALOX5PRKDCTDP1CYP1A2TNKS | |
| SCHEMBL17562308 | 0.89 | ALOX5 (0.43) | ALOX5PRKDCTNKSTNKS2 | |
| SCHEMBL16373669 | 0.89 | ALOX5 (0.43) | ALOX5PRKDCTNKSTNKS2 | |
| SCHEMBL12088698 | 0.89 | ALOX5 (0.35) | ALOX5PRKDCTDP1 | |
| SCHEMBL780864 | 0.88 | ALOX5 (0.50) | ALOX5PRKDCTDP1CYP1A2CYP2C9 | |
| SCHEMBL780768 | 0.88 | ALOX5 (0.50) | ALOX5PRKDCCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL11885216 | 0.87 | ALOX5 (0.46) | ALOX5PRKDCTNKSTNKS2 | |
| SCHEMBL23468825 | 0.86 | ALOX5 (0.41) | ALOX5PRKDCTDP1CYP1A2TNKS | |
| SCHEMBL16641532 | 0.86 | ALOX5 (0.41) | ALOX5PRKDCTNKSTNKS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220416178-A1 | COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS | IDEMITSU KOSAN CO.,LTD. (JP) | 2022-12-29 | — | — | US | disclosed |
| US-10230057-B2 | Biscarbazole derivatives and organic electroluminescence device employing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2019-03-12 | — | — | US | disclosed |
| US-20180047917-A1 | BISCARBAZOLE DERIVATIVES AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME | IDEMITSU KOSAN CO., LTD (JP) | 2018-02-15 | — | — | US | disclosed |
| US-20180047917-A1 | BISCARBAZOLE DERIVATIVES AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME | IDEMITSU KOSAN CO., LTD (JP) | 2018-02-15 | — | — | US | disclosed |
| US-9818958-B2 | Biscarbazole derivatives and organic electroluminescence device employing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2017-11-14 | — | — | US | disclosed |
| US-9818958-B2 | Biscarbazole derivatives and organic electroluminescence device employing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2017-11-14 | — | — | US | disclosed |
| US-20160240795-A1 | BISCARBAZOLE DERIVATIVES AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2016-08-18 | — | — | US | disclosed |
| US-20160240795-A1 | BISCARBAZOLE DERIVATIVES AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2016-08-18 | — | — | US | disclosed |
| US-9373802-B2 | Biscarbazole derivatives and organic electroluminescence device employing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2016-06-21 | — | — | US | disclosed |
| US-9373802-B2 | Biscarbazole derivatives and organic electroluminescence device employing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2016-06-21 | — | — | US | disclosed |
| US-20140312331-A1 | BISCARBAZOLE DERIVATIVES AND ORGANIC ELECTROLUMINESCENCE | IDEMITSU KOSAN CO., LTD. (JP) | 2014-10-23 | — | — | US | disclosed |
| US-20140312331-A1 | BISCARBAZOLE DERIVATIVES AND ORGANIC ELECTROLUMINESCENCE | IDEMITSU KOSAN CO., LTD. (JP) | 2014-10-23 | — | — | US | disclosed |
| US-8803134-B2 | Biscarbazole derivatives and organic electroluminescence | IDEMITSU KOSAN CO., LTD. (JP) | 2014-08-12 | — | — | US | disclosed |
| US-8803134-B2 | Biscarbazole derivatives and organic electroluminescence | IDEMITSU KOSAN CO., LTD. (JP) | 2014-08-12 | — | — | US | disclosed |
| US-20120223295-A1 | BISCARBAZOLE DERIVATIVES AND ORGANIC ELECTROLUMINESCENCE | IDEMITSU KOSAN CO., LTD. (JP) | 2012-09-06 | — | — | US | disclosed |
| US-20120223295-A1 | BISCARBAZOLE DERIVATIVES AND ORGANIC ELECTROLUMINESCENCE | IDEMITSU KOSAN CO., LTD. (JP) | 2012-09-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220416178-A1 | COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS | PIEZO1, TMEM109, SLC39A14 | ALOX5 3499/4885PRKDC 3445/4885TDP1 2409/4885 |
| US-20180047917-A1 | BISCARBAZOLE DERIVATIVES AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME | EED, GABRE, EML4 | ALOX5 747/4885PRKDC 3040/4885TDP1 2592/4885 |
| US-20120223295-A1 | BISCARBAZOLE DERIVATIVES AND ORGANIC ELECTROLUMINESCENCE | EED, GABRE, EML4 | ALOX5 877/4885PRKDC 3069/4885TDP1 2754/4885 |
| US-10230057-B2 | Biscarbazole derivatives and organic electroluminescence device employing the same | EED, GABRE, EML4 | ALOX5 747/4885PRKDC 3040/4885TDP1 2592/4885 |
| US-20140312331-A1 | BISCARBAZOLE DERIVATIVES AND ORGANIC ELECTROLUMINESCENCE | EED, GABRE, EML4 | ALOX5 877/4885PRKDC 3069/4885TDP1 2754/4885 |
| US-20160240795-A1 | BISCARBAZOLE DERIVATIVES AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME | EED, GABRE, EML4 | ALOX5 747/4885PRKDC 3040/4885TDP1 2592/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.